BTProf. Dr. Burak TatlıÇocuk Nörolojisi ve Gelişim
Chapter 26 · Treatment

Cannabidiol and New Treatments

Prof. Dr. Burak Tatlı
Written and medically reviewed by
Prof. Dr. Burak Tatlı

Specialist in Pediatric Neurology & Developmental Pediatrics

İstanbul University-Cerrahpaşa Faculty of Medicine · Nörogender Association

Last reviewed:

Epilepsy treatment is a constantly evolving field. In recent years, promising new treatments have been developed, especially for severe and resistant syndromes. This chapter introduces these developments within a realistic framework.

Pharmaceutical Cannabidiol (CBD)

Cannabidiol (CBD), one of the compounds obtained from the cannabis plant, has in recent years earned a scientifically proven place in treating certain severe childhood epilepsies. What we're talking about here isn't over-the-counter products or “hemp oil”; it's a standard, purified, medical form of the drug. CBD has been approved because it was shown to reduce seizures when added to other medicines, especially in resistant syndromes such as Dravet syndrome and Lennox-Gastaut syndrome.

A very important warning

Medical cannabidiol should be used only under a doctor's supervision, by prescription, and as a standard medicine. It can interact with other medicines and requires liver monitoring.

Unregulated cannabis/CBD products sold online or through various sources can be dangerous for your child, because their contents and purity are uncertain. Never use these without consulting your doctor.

Targeted and Personalized Treatments

Advances in genetics and molecular medicine are opening a new era in epilepsy treatment. For some genetic epilepsies, “targeted” treatments are being developed that act directly on the specific mechanism underlying the disease. New molecules approved specifically for certain syndromes offer additional options in resistant cases. In the future, personalized treatments shaped around a child's own genetic profile are expected to become more widespread.

Clinical Research

For some children with drug-resistant epilepsy, taking part in clinical research where new treatments are being tested can be an option. This research may provide access to treatments not yet in widespread use, but it also involves uncertainties. If such an option comes up, talk through the details of the process and the possible benefits and risks thoroughly with your epilepsy center.

Balancing hope with realism

New treatments are exciting and genuinely hold promise. But not every new treatment is suitable for every child.

Share every “miracle cure” you read about online with your doctor, and together choose what is evidence-based and right for your child. A healthy hope is a hope nourished by knowledge.

Bu site yalnızca bilgilendirme amaçlıdır. İçerikler tanı, tedavi veya reçete yerine geçmez; doktorunuzun bakımının yerini almaz.